Drug abates symptoms in two genetic models of autism

Drugs developed to treat fragile X syndrome may also work for autism because both disorders feature defects at neuronal junctions, or synapses, suggests a paper.

Researchers showed that CTEP, a drug designed to target the defect in fragile X syndrome, alleviates cognitive problems in mice that model deletion of the autism-linked 16p11.2 chromosomal region.